Versican antibody (AA 362-585)
Quick Overview for Versican antibody (AA 362-585) (ABIN1686648)
Target
See all Versican (Vcan) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 362-585
-
Specificity
- Detects >350 kDa.
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Protein G Purified
-
Immunogen
- Fusion protein amino acids 362-585 (glycosaminoglycan alpha domain) of mouse Versican core protein
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
- WB (1:1000)
- ICC/IF (1:100)
- optimal dilutions for assays should be determined by the user.
-
Comment
-
1 μg/ml of ABIN1686648 was sufficient for detection of Versican in 20 μg of mouse brain membrane lysate and assayed by colorimetric immunoblot analysis using goat anti-mouse IgG:HRP as the secondary antibody.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4, 50 % glycerol, 0.1 % sodium azide, Storage buffer may change when conjugated
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- Versican (Vcan)
-
Alternative Name
- Versican
-
Background
- Versican (chondroitin sulfate proteoglycan 2) is a large extracellular matrix proteoglycan involved in cell growth and differentiation. Important as a structural molecule, versican creates loose and hydrated matrices during key events in development and disease. The protein contains hyaluronic acid and glycosminoglycan-binding domains, epidermal growth factor-like repeats, a Lectinlike sequence and a complement regulatory protein-like domain. Splice variants differ greatly in length anddegree of modification by glycoaminoglycan chains. Accumulation around smooth muscle cells in lesions of athero-sclerosis suggests a role for versican in atherogenesis. Versican, differentially expressed in human melanoma, plays a role in tumor development and may be a reliable marker for clinical diagnosis. The organization of HA- and versican-rich pericellular matrices may faciliatate migration and mitosis by diminishing cell surface adhesivity and affecting cell shape through steric exclusion and the viscous properties of HA proteoglycan gels.
-
Gene ID
- 13003
-
UniProt
- Q62059
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-